Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
A flexible approach to
Phase II-IVClinicalServices
QPS IS A GLOBAL CRO WITH DIVERSE CAPABILITES THAT OFFERS END TO END
SERIVCES TO PHARMA AND BIOPHARMA COMPANIES enabling them to bring products to
market in a faster and more compliant manner. With operations in India, USA, Europe and Taiwan, QPS is ideally positioned to address the key global
generic product development requirements of quality, compliance, and time to market.
TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT.CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY!
CALL +1 512 350 2827 EMAIL [email protected]
www.qps.com | [email protected] | +1 512-350-2827 FLEXIBILITY. AGILITY. SPEED.
Services Offered • Biostatistics
• Data Management
• Medical Writing
• Monitoring
• Pharmacogenomics (RNA/DNA) Pharmacovigilance
• PK/PD evaluation
• Program, Project and Study Management Regulatory Affairs
Therapeutic Area Focus • CNS - including Parkinson's Disease and Alzheimer's Disease
• Endocrinology - including Diabetes and Obesity
• Oncology
• Pulmonary/Respiratory - including Asthma, Emphysema and COPD
• Dermatology - Dermal and Transdermal delivery systems
• Vaccines - Flu, RSV, Hepatitis, HPV, Ebola, Zika, and others!
Why Choose Qps For Phase II-IV Services? • Boutique style CRO providing the highest level of customized service.
• Global footprint with 11 locations in Asia, Europe and North America.
• Low turn-over of staff
• Monitoring efficiency increased by strategic site and study support
• Access to a large network of investigators across therapeutic areas
• Experienced personnel with medical, regulatory and cultural knowledge
• Direct access to scientists
The Global Footprint Of QPS
QPS India:
• Extensive experience with generic and biosimilar studies
• Fast recruitment of patients
QPS Missouri
• All 5 units available for Phase II-IV trials
• PI Experience: Family Practice, Skin Cancer & Hepatitis C
Specialists, Ophthalmology
QPS Netherlands
• Capable of monitoring studies in several countries
(Belgium, Northern Germany, NL, UK)
• Cardiology studies are well promoted in NL, with good
recruitment rates
QPS Taiwan
• Fast governmental regulatory approval to start studies
• Clinical Research Coordinators with UNITIX, an SMO, can
increase study efficiency
QPS Austria
• Clinical studies have involved over 15,000 subjects
• In-depth knowledge and understanding of European and
local regulations
QPS Miami
• Over 1,200 clinical trials conducted across Phase 1, Late Phase
and Vaccines
• A robust database of 30,000 subjects/patients
WWW.QPS.COM
CALL +1 512 350 2827
EMAIL [email protected]
QPS is a Global CRO with locations around the world
to serve the evolving needs of the Pharmaceutical and Biotech industries
Fargo, ND, USADermal and Transdermal
Research Services (DTRS)
Groningen and Leeuwarden,
The NetherlandsBioanalysis (BA)
Clinical Research Services (CRS)
Translational Medicine (TLM)
Suzhou and Shanghai,
ChinaBioanalysis
Clinical Research Services (CRS)
Miami, FL, USAClinical Research
Services (CRS)
Hyderabad, IndiaClinical Research
Services (CRS)
Taipei, TaiwanBioanalysis (BA)
Clinical Research Services (CRS)
Toxicology (TOX)
Translational Medicine (TLM)
Newark, DE, USABioanalysis (BA)
Clinical Research Services (CRS)
DMPK
Translational Medicine (TLM)
Global Headquarters for
QPS Holdings LLC
Graz, AustriaClinical Research Services (CRS)
DMPK
Histology Services
Neuropharmacology
Orphan/Rare Disease
Rodent Biobank
Springfield, MO, USAClinical Research
Services (CRS)
Phase II - IVClinical Services